|
myocardial infarction |
14 |
|
cardiomyocytes |
13 |
|
animals |
12 |
|
embryonic stem cells |
11 |
|
proarrhythmias |
11 |
|
bradykinin |
8 |
|
cardiac differentiation |
8 |
|
cell differentiation - drug effects |
8 |
|
cell line |
8 |
|
cell movement - drug effects |
8 |
|
embryonic stem cell |
8 |
|
embryonic stem cells - cytology - drug effects - transplantation |
8 |
|
endothelial cells |
8 |
|
ferric compounds - adverse effects |
8 |
|
green fluorescent proteins - analysis - biosynthesis |
8 |
|
heart failure |
8 |
|
induced pluripotent stem cells |
8 |
|
magnetic resonance imaging - methods |
8 |
|
mice |
8 |
|
myocytes, cardiac - cytology - drug effects |
8 |
|
nanoparticles - adverse effects |
8 |
|
staining and labeling - methods |
8 |
|
superparamagnetic iron oxide |
8 |
|
arrhythmias, cardiac - etiology |
7 |
|
embryonic stem cells - transplantation |
7 |
|
myocytes, cardiac - transplantation |
7 |
|
stem cell transplantation - adverse effects |
7 |
|
ventricular remodeling - physiology |
7 |
|
epicardial patch |
6 |
|
myocardial infarction - pathology - physiopathology - surgery |
6 |
|
pericardium - pathology - physiopathology |
6 |
|
prosthesis implantation - methods |
6 |
|
spinal cord stimulation |
6 |
|
swine |
6 |
|
ventricular dysfunction, left - physiopathology - surgery |
6 |
|
ventricular remodeling |
6 |
|
bone marrow |
5 |
|
bone marrow transplantation - methods - physiology |
5 |
|
cardiomyopathy |
5 |
|
cell count |
5 |
|
cell differentiation |
5 |
|
chronic disease |
5 |
|
electrophysiologic techniques, cardiac |
5 |
|
embryonic stem cell-derived mesenchymal stem cells |
5 |
|
flow cytometry |
5 |
|
immunohistochemistry |
5 |
|
ischaemic myocardium |
5 |
|
leukocytes, mononuclear - physiology |
5 |
|
microspheres |
5 |
|
myocardial ischemia - physiopathology |
5 |
|
myocardial revascularization - methods |
5 |
|
myocardium - metabolism |
5 |
|
neovascularization |
5 |
|
neovascularization, physiologic |
5 |
|
paracrine communication |
5 |
|
pulmonary arterial hypertension |
5 |
|
stem cells - physiology |
5 |
|
swine, miniature |
5 |
|
vascular endothelial growth factor a - metabolism |
5 |
|
ventricular function, left |
5 |
|
ablation |
4 |
|
anthracyclines |
4 |
|
apocynin |
4 |
|
bms309403 |
4 |
|
body temperature |
4 |
|
bone marrow cells - pathology |
4 |
|
cardiology |
4 |
|
catheter ablation - methods |
4 |
|
caveolin-3 |
4 |
|
cell therapy |
4 |
|
diabetes |
4 |
|
diastole |
4 |
|
diffusion magnetic resonance imaging - methods |
4 |
|
dti |
4 |
|
endothelium |
4 |
|
epithelial-mesenchymal transition |
4 |
|
female |
4 |
|
fish oil |
4 |
|
gi proteins |
4 |
|
heart failure - etiology |
4 |
|
histamine |
4 |
|
hypertension |
4 |
|
hyperthyroidism - complications - epidemiology - physiopathology |
4 |
|
in farct size |
4 |
|
infarct location |
4 |
|
ipsc-induced hepatocytes |
4 |
|
ischaemic heart disease |
4 |
|
kir2.1 |
4 |
|
lesion |
4 |
|
mesenchymal stem cells |
4 |
|
mesenchymal stromal cell |
4 |
|
microarray |
4 |
|
microwave |
4 |
|
microwaves - therapeutic use |
4 |
|
muscle, skeletal - pathology - physiology - surgery |
4 |
|
myoblasts, skeletal - pathology |
4 |
|
myocardial fiber |
4 |
|
myocardial infarction - pathology |
4 |
|
myocardial infarction - pathology - physiopathology - therapy |
4 |
|
myocardial ischaemia/reperfusion injury |
4 |
|
myocardium - metabolism - pathology |
4 |
|
myocardium infarction |
4 |
|
polyunsaturated fatty acids |
4 |
|
porcine coronary artery angioplasty |
4 |
|
protein kinase cβ |
4 |
|
radiofrequency |
4 |
|
regeneration |
4 |
|
remodeling |
4 |
|
stem cell transplantation |
4 |
|
stem cells |
4 |
|
vascular resistance |
4 |
|
ventricular dysfunction, left - epidemiology - etiology - physiopathology - ultrasonography |
4 |
|
ventricular dysfunction, left - pathology |
4 |
|
arrhythmia |
3 |
|
biomarkers |
3 |
|
bone marrow cells |
3 |
|
cardiac progenitor cells |
3 |
|
cardiomyocyte |
3 |
|
cardiomyopathies |
3 |
|
cardiospheres |
3 |
|
connecxin 43 |
3 |
|
denervation |
3 |
|
human induced pluripotent stem cell |
3 |
|
immunomodulation |
3 |
|
ischemia |
3 |
|
ischemic cardiomyopathy |
3 |
|
mesenchymal stem cell |
3 |
|
models, animal |
3 |
|
myocardial regeneration |
3 |
|
nerve sprouting |
3 |
|
pacing |
3 |
|
pluripotent stem cells |
3 |
|
skin fibroblast |
3 |
|
somatic reprogramming |
3 |
|
sympathetic innervation |
3 |
|
bioengineering cardiac patch |
2 |
|
cardiac regeneration and repair |
2 |
|
decellularized placenta |
2 |
|
exosome |
2 |
|
intramyocardial injection |
2 |
|
issue 159 |
2 |
|
left ventricular function |
2 |
|
medicine |
2 |
|
myocardial infarction - treatment |
2 |
|
myocardial repair |
2 |
|
norepinephrine |
2 |
|
renal denervation |
2 |
|
stem cells - therapeutic use |
2 |
|
ventricular remodeling - prevention |
2 |
|
acid-sensitive ion channels 1a |
1 |
|
cardiac shock wave |
1 |
|
endoplasmic reticulum stress |
1 |
|
inflammation |
1 |
|
macrophages |
1 |
|
mesemchymal stem cells |
1 |
|
rejuvenation |
1 |
|
senescence |
1 |
|
therapy |
1 |
|
transplantation |
1 |
